Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2026 09:32 ET | Source: 24/7 Market News

Morning Market Pulse: From Orbit to Biomaterials, Innovation Drives the Tape

flyExclusive (NYSE American: FLYX), Kraig Labs (OTCQB: KBLB), Aclarion (NASDAQ: ACON), and MoonLake Immunotherapeutics (NASDAQ: MLTX) are today’s leaders
December 14, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MoonLake Immunotherapeutics investors that lost money are encouraged to contact BG&G before the December 15, 2025 lead plaintiff deadline.
December 13, 2025 07:18 ET | Source: Bleichmar Fonti & Auld

MLTX FRAUD UPDATE: Important MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 15

Important MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 15
December 11, 2025 08:08 ET | Source: Bleichmar Fonti & Auld

MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action

MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action
December 10, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MoonLake Immunotherapeutics investors that lost money are encouraged to contact BG&G before the December 15, 2025 lead plaintiff deadline.
December 09, 2025 08:33 ET | Source: Bleichmar Fonti & Auld

MLTX LAWSUIT ALERT: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses

MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses
December 07, 2025 07:18 ET | Source: Bleichmar Fonti & Auld

MLTX INVESTOR LOSSES: Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline

Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline
December 05, 2025 08:18 ET | Source: Bleichmar Fonti & Auld

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law if You Lost Money

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law
December 03, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MoonLake Immunotherapeutics investors that lost money are encouraged to contact BG&G before the December 15, 2025 lead plaintiff deadline.
December 03, 2025 07:46 ET | Source: Bleichmar Fonti & Auld

MLTX NEWS: MoonLake Immunotherapeutics Sued for Securities Fraud after Stock Plummets 90% -- Investors Notified to Contact BFA Law by December 15 Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.